<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A Native American-Indian female presenting with <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> was diagnosed with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, <z:hpo ids='HP_0005505'>refractory anemia</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>Over the course of 5 years she developed cytopenias and periods of <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> with <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow (BM) blast counts, features of an <z:e sem="disease" ids="C0854809" disease_type="Neoplastic Process" abbrv="">unclassifiable MDS</z:e>/MPS syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>The patient ultimately progressed to <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:e sem="disease" ids="C0026999" disease_type="Neoplastic Process" abbrv="">FAB M2</z:e>) and had a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype throughout her course </plain></SENT>
<SENT sid="3" pm="."><plain>The episodes of <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> were associated with infectious complications </plain></SENT>
<SENT sid="4" pm="."><plain>Transformation to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> was characterized by a BM blast percentage of 49% </plain></SENT>
<SENT sid="5" pm="."><plain>Peripheral blood and BM samples were obtained for serum protein analysis and gene expression profiling (GEP) to elucidate <z:e sem="disease" ids="C0017925" disease_type="Disease or Syndrome" abbrv="">her disease</z:e> process </plain></SENT>
<SENT sid="6" pm="."><plain>An ELISA assay of the serum analyzed approximately 80 cytokines, which demonstrated that hepatocyte growth factor/scatter factor and insulin-like growth factor binding protein 1 were markedly elevated compared to <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>GEP demonstrated a unique "<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> molecular profile," which included overexpression of oncogenes (HOXA9, N-MYC, KOC1), proliferative genes (PAWR, DLG5, AKR1C3), invasion/metastatic genes (FN1, N-CAM-1, ITGB5), pro-<z:mpath ids='MPATH_177'>angiogenesis</z:mpath> genes (c-Kit), and down regulation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes (SUI1, BARD1) and anti-apoptotic genes (PGLYRP, SERPINB2, MPO) </plain></SENT>
<SENT sid="8" pm="."><plain>Hence, a biomics approach has provided insight into elucidating disease mechanisms, molecular prognostic factors, and discovery of novel targets for therapeutic intervention </plain></SENT>
</text></document>